• $211.8M
    Market Cap
  • -68.90%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.20
$0.20
$0.20
1-Year Range
$0.20
$0.96
$0.20
Latest Close$0.20
Change
$0.00 (0.00%)
Volume159
Market Cap$211.8M
Shares Outstanding1.0B
P/E (TTM)-2,020.00
Diluted EPS (TTM)-$0.0001
Enterprise Value$212.1M

Information as of 06/03/2026

Company Profile

NIKA PHARMACEUTICALS, INC
https://www.nikapharmaceuticals.com
$211.8M
Market Cap
-$76,812.00
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
2269 Merrimack Valley Avenue, Henderson, NV, United States, 89044
702 326 3615

Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

Key Executives

  • Dimitar Slavchev Savov
  • Clifford Redekop

Current Ownership Distribution

  • Other1.0B (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)